Research & Development Market Research Reports & Industry Analysis
Bringing R&D costs and times down, therefore, means there are many opportunities to improve efficiencies, advance technological innovation, and economize and optimize. The pharmaceutical R&D category tracks both drug pipeline reports, competitive R&D strategies, and markets important and ancillary to the research efforts themselves, including activities in the biotech and sector that impinge upon the process.
Research & Development Industry Research & Market Reports
-
The 2026-2031 World Outlook for Knockout Rat Models
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
The 2026-2031 World Outlook for Humanized Liver Mice Models
... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More
-
Global Human Liver Model Market: Analysis By Product Type (2D Human Liver Model and 3D Human Liver Model), Application (ADME Studies, Toxicology Testing, Disease Modeling and Others), By End-use (Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic and Research Institutes), By Region Size and Trends with Forecast up to 2030
... applications in drug discovery, toxicology testing, disease modeling, regenerative medicine, and personalized healthcare. Traditional liver research relied heavily on animal models and 2D cell cultures, but these approaches often fall short of accurately replicating human ... Read More
-
Biotechnology Research Services
... US organizations engaged in biotechnology research include the Howard Hughes Medical Institute (HHMI), the Jackson Laboratory (JAX), and Scripps Research; institutes affiliated with government research agencies and major universities, such as the Whitehead Institute (MIT); ... Read More
-
Global PARP (poly Adp-ribose Polymerase) Inhibitors Market 2025-2029
... report on the parp (Poly ADP-Ribose Polymerase) inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Global Organoids Market - 2025-2033
... organoids market is growing due to technological advancements, increased research funding, and the demand for accurate and ethical models in biomedical research. Organoids, which are three-dimensional in vitro tissue constructs derived from stem cells, mimic ... Read More
-
Digital Pathology Market by Product (Scanner, Software, Storage System), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma & Biotech, Academia, Hospitals) - Global Forecast to 2030
... largest share of the product category in 2024. Scanners are critical in enabling pathologists to view and analyze tissue samples on computer screens, as scanners convert physical glass slides to high-resolution digital images. The development ... Read More
-
Growth Factors (Blood and Tissue)
... Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Interferons, one of the segments analyzed in the report, is expected to record a 10.1% CAGR and reach US$78.2 Billion by ... Read More
-
RNA Interference (RNAi)
... at a CAGR of 10.0% over the analysis period 2024-2030. Drug Discovery & Development, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$118.1 Billion by the ... Read More
-
Healthcare Contract Development and Manufacturing Organization
... reach US$547.1 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2024-2030. Contract Manufacturing, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach ... Read More
-
Genomics in Cancer Care
... 2030, growing at a CAGR of 16.7% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 15.4% CAGR and reach US$25.0 Billion by the end ... Read More
-
Simultaneous-Functionality Analyzers
... CAGR of 5.0% over the analysis period 2024-2030. Chemical & Material Manufacturers, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$134.6 Million by the end of ... Read More
-
Patient Derived Xenograft / PDX Models
... reach US$1.0 Billion by 2030, growing at a CAGR of 14.3% over the analysis period 2024-2030. Mice PDX Models, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and ... Read More
-
Humanized Mouse and Rat Model
... Million by 2030, growing at a CAGR of 7.3% over the analysis period 2024-2030. Oncology, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$74.5 Million by ... Read More
-
Protein Binding Assays
... at a CAGR of 9.4% over the analysis period 2024-2030. Equilibrium Dialysis, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$342.2 Million by the end of ... Read More
-
Cold Plasma
... CAGR of 14.7% over the analysis period 2024-2030. Polymer & Plastics, one of the segments analyzed in the report, is expected to record a 13.9% CAGR and reach US$1.7 Billion by the end of the ... Read More
-
Bioburden Testing
... CAGR of 11.3% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 11.8% CAGR and reach US$1.5 Billion by the end of the analysis period. ... Read More
-
Human Embryonic Stem Cell (hESC) Research
... reach US$1.4 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Regenerative Medicine, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach ... Read More
-
In Vivo Contract Research Organization (CRO)
... reach US$8.0 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Smalll Molecules Modality, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and ... Read More
-
Biotech Flavors
... CAGR of 6.7% over the analysis period 2024-2030. Vanilla & Vanillin, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$872.9 Million by the end of the ... Read More
-
Viral Vector Manufacturing
... at a CAGR of 18.3% over the analysis period 2024-2030. Retroviral Vectors, one of the segments analyzed in the report, is expected to record a 18.1% CAGR and reach US$954.6 Million by the end of ... Read More
-
Neuroscience
... 3.9% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$29.9 Billion by the end of the analysis period. Growth in ... Read More
-
Biotech Business June 2025
... on biotechnology products and companies. It reports which universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies and their expected growth or decline. Read More
-
Biophotonics
... 10.8% over the analysis period 2024-2030. See-through Imaging, one of the segments analyzed in the report, is expected to record a -1.6% CAGR and reach US$34.1 Billion by the end of the analysis period. Growth ... Read More
-
Biobanks
... 7.7% over the analysis period 2024-2030. Physical / Real, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$108.4 Billion by the end of the analysis period. ... Read More
Research Assistance
